Your browser doesn't support javascript.
loading
A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S).
Kobayashi, Eiji; Kanao, Hiroyuki; Takekuma, Munetaka; Nishio, Shin; Kojima-Chiba, Atsumi; Tozawa, Akiko; Yamaguchi, Satoshi; Takeshima, Nobuhiro; Nakatani, Eiji; Mikami, Mikio.
Afiliação
  • Kobayashi E; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan. ekobayashi@gyne.med.osaka-u.ac.jp.
  • Kanao H; Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Takekuma M; The Division of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nishio S; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan.
  • Kojima-Chiba A; Department of Obstetrics and Gynecology, Faculty of Medicine, Iwate Medical University, Morioka, Japan.
  • Tozawa A; Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Yamaguchi S; Department of Gynecologic Oncology, Hyogo Cancer Center, Hyogo, Japan.
  • Takeshima N; Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Nakatani E; Division of Statistical Analysis of Research Support Center, Shizuoka General Hospital, Shizuoka, Japan.
  • Mikami M; Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan.
Int J Clin Oncol ; 26(2): 417-428, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33433752
ABSTRACT

OBJECTIVE:

To evaluate the safety and efficacy of laparoscopic radical hysterectomy (LRH) for cervical cancer, in terms of morbidity and short-term oncologic outcome following LRH's introduction into Japan.

METHODS:

We conducted a retrospective analysis of patients with early-stage cervical cancer (FIGO staging IA2, IB1, and IIA1) who underwent LRH from Dec 2014 to Dec 2016. We assessed the morbidity, overall survival (OS) and recurrence-free survival (RFS), and prognostic factors for RFS.

RESULTS:

A total of 251 patients were included from 22 facilities across Japan. There were 8 cases of stage IA2 cervical cancer, 226 of IB1, and 17 of IIA1. The median operating time was 343 min and the median blood loss was 190 ml. Two patients (0.8%) had a postoperative complication with a Clavien-Dindo classification of grade 3 or higher. After a median follow-up time of 15.6 months, the 2-year RFS was 87.4%, and the 2-year OS was 97.8%. When the 2-year RFS rate was compared with whether the patient pathologically had tumors of less than 2 cm, versus 2 cm or more, the RFS was 95.8% and 80.4%, respectively. Multivariate analysis found that tumor size and the route of lymph node removal were independent prognostic factors for recurrence.

CONCLUSION:

When LRH was first introduced into Japan, we found that the route of lymph node removal was an independent prognostic factor for recurrence in addition to large tumors (≥ 2 cm). Our results suggest that prognosis may be secured by paying attention to the lymph node removal route.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Histerectomia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Histerectomia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article